Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Nov 12, 2024 · Filed Nov 14, 2024
Dariohealth's Chief Commercial Officer paid $4.5K out of pocket for Dariohealth shares. It was the first purchase in over a year. Shares held went up 10% with this purchase.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$4,546
Shares × reported transaction price
<$25K
+10.0%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
None in 13 months of history
Confirmed open-market purchases by the same insider in the available history
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
This purchase equals less than 1% of the average reported total pay of the company's named executive officers other than the CEO, fiscal 2023 ($879K)
An average across the officers named in the pay versus performance table of the company's proxy statement (DEF 14A), filed 2025-12-22. This person may not be one of them, so it is not their own pay. A size comparison, not a judgement
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +9.6% | +1.7% | +7.9% |
| 30 days | −8.7% | +3.6% | −12.3% |
| 90 days | −15.7% | +4.1% | −19.8% |
| 180 days | −14.4% | +0.3% | −14.7% |
| 365 days | −9.4% | +13.6% | −23.0% |
Past results only. Not a forecast.